The Drug Supply Chain Security Act, or DSCSA, establishes national standards for securing the United States prescription drug channel from the pharmaceutical manufacturer all the way to the dispenser.

Let’s Talk

Pharmaceutical Distribution Supply Chain

Who touches the drug before it reaches the patient?

DSCSA graphic
Launch analog icon

The goals of legislation are to allow for greater trust and transparency while standardizing data exchange and providing a way to recognize suspect and illegitimate products through serialization.

However, it will also bring new rules and regulations to drug companies, creating an increased opportunity for potential mistakes and pitfalls. Mistakes that can cost you time and money by preventing the distribution of products and incurring fines/penalties (even jail time).

The DSCSA has several provisions, allowing the FDA the authority to draft additional requirements and enforcement criteria, which can suddenly put your drug out of compliance. We will remain vigilant, watching for any changes and adjusting plans to make sure you remain DSCSA compliant.

How We Can Help

To remain compliant with the DSCSA, serialization is key; however, a number of new Standard Operating Procedures (SOPs) must be established, new data connections must be formed, and additional barcoding and labeling requirements must be integrated into your packaging plans.

Magnifying glass icon

Two Labs can leverage industry experience and knowledge to keep you in good standing through this emerging and seemingly ever-changing system:

  • Provide neutral, 3rd party education on the DSCSA requirements so your organization is fully aware of regulatory obligations

  • Attend industry conferences and participate in DSCSA working groups to ensure you are on the forefront of industry best practices

  • Stay up to date on new FDA guidance documents

  • Advise your organization through the serialization data provider selection process

  • Advise your packager when deficiencies are identified

  • Project Management support with the integration of serialization system(s) and your packaging and trading partners

  • Provide guidance and assistance to ensure SOPs are in alignment with DSCSA requirements and your internal quality procedures

  • Review/scan labels to ensure they meet HDA & GS1 guidelines (which downstream trading partners require)

  • Assist in creation of required master data elements for serialization

Get on the Smartest Route to Your Pharma Product Journey with Two Labs

We Lead Pharma Manufacturers Through the Commercial Strategy and Operations Journey

We Have Deep Experience Supporting Pharma Manufacturers

280+

New Product Launches

310+

Active Clients

150+

Experienced Consultants

Let’s Talk

Contact Us Today to Request a Free Consultation

At Two Labs, we’re excited to see what new capabilities the DSCSA brings to the pharmaceutical industry, but we also realize that it will put a lot of stress on drug manufacturers. We’re here to help lighten the load, making sure your transition to DSCSA compliance is as easy as possible.

If you have any questions about Two Labs’ capabilities and how we can help with ensuring your DSCSA compliance, contact us for a consultation.

Additional DSCSA Insights

DSCSA Preparation

Are you ready for the November Saleable Returns Verification requirement?

Download our free paper, DSCSA: What You Need to Know about the Saleable Returns Verification before November, to learn more.

Download our Paper

How DSCSA Changes the Licensing Landscape for Third-Party Logistics

The Drug Supply Chain Security Act (DSCSA), passed in November 2013, has become a buzzword in the pharma industry in the past few years, and will continue to be until the completion of the implementation in 2023. DSCSA describes creating an electronic, inter operable system that stores transaction information and history of a drug…

Read More